An important problem with DMARDs for example adalimumab, etanercept, and abatacept is the improved risk of significant infections. People with liver disease need to steer clear of using methotrexate and leflunomide. https://harmonyqhzp440964.gynoblog.com/28569137/helping-the-others-realize-the-advantages-of-osteoarthritis-knee-surgery-options